Clinical Trial Update: Avenir Müller Hip Stem Post Market Surveillance Study

View source ↗

Summary

Post-market surveillance study for the Avenir Müller Hip Stem completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dislocated Hip
• Fracture of Hip
• Osteoarthritis of the Hip
• Osteonecrosis
• Post-traumatic Arthrosis
• Rheumatoid Arthritis
• Subluxation of Hip

Drugs mentioned

• Avenir Müller Hip Stem

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Hip, Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2020-06-23